Trials / Completed
CompletedNCT02607683
Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
A Phase 2b/3, Multicenter, Dose-ranging, Randomized, Double-masked, Placebo-controlled Study of XAF5 Ointment for Reduction of Lower Lid Steatoblepharon
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Topokine Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | XAF5 (concentration A: 0.1%) | |
| DRUG | XAF5 (concentration B: 0.035%) | |
| DRUG | Matching placebo |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-09-19
- Completion
- 2016-10-31
- First posted
- 2015-11-18
- Last updated
- 2017-11-08
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02607683. Inclusion in this directory is not an endorsement.